Symbotic Inc. reported its financial results for Q4 and fiscal year 2025, with revenue of $618 million, a net loss of $19 million, and adjusted EBITDA of $49 million. Cash and cash equivalents increased to $1.245 billion, reflecting growth in operational systems and strong margin expansion compared to the prior year.

For the full fiscal year 2025, Symbotic reported revenue of $2.247 billion, a net loss of $91 million, and adjusted EBITDA of $147 million. The company added Medline as its first customer in the health care vertical and expects revenue of $610-630 million and adjusted EBITDA of $49-53 million for Q1 of fiscal 2026.

Symbotic is hosting a webcast to discuss its financial results. Adjusted EBITDA, gross profit, research and development expenses, selling, general, and administrative expenses, and free cash flow are key financial metrics the company focuses on. Forward-looking statements include expectations for future financial and business performance or conditions.

Read more at GlobeNewswire: Symbotic Reports Fourth Quarter and Fiscal Year 2025